These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 4723308)

  • 1. Contributions of host and intestinal microflora in the metabolism of L-dopa by the rat.
    Goldin BR; Peppercorn MA; Goldman P
    J Pharmacol Exp Ther; 1973 Jul; 186(1):160-6. PubMed ID: 4723308
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary metabolites from rats given L-DOPA.
    Borud O; Midtvedt T; Gjessing LR
    Acta Pharmacol Toxicol (Copenh); 1972; 31(5):540-9. PubMed ID: 4678834
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of intestinal bacteria in the metabolism of salicylazosulfapyridine.
    Peppercorn MA; Goldman P
    J Pharmacol Exp Ther; 1972 Jun; 181(3):555-62. PubMed ID: 4402374
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic implications in Parkinsonism of m-tyramine formation from L-dopa in man.
    Sandler M; Goodwin BL; Ruthven CR
    Nature; 1971 Feb; 229(5284):414-5. PubMed ID: 4926994
    [No Abstract]   [Full Text] [Related]  

  • 5. The metabolism of umbelliferone and herniarin in rats and by the rat intestinal microflora.
    Indahl SR; Scheline RR
    Xenobiotica; 1971 Jan; 1(1):13-24. PubMed ID: 5163172
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic implications of the intestinal microflora.
    Goldman P
    N Engl J Med; 1973 Sep; 289(12):623-8. PubMed ID: 4146730
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism of drugs by microorganisms in the intestine.
    Goldman P; Peppercorn MA; Goldin BR
    Am J Clin Nutr; 1974 Nov; 27(11):1348-55. PubMed ID: 4155602
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism of D- vs L-Dopa.
    Arras MJ
    N Engl J Med; 1970 Apr; 282(14):813. PubMed ID: 5416979
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the metabolism and excretion of L-3,4-dihydroxyphenylalanine (L-DOPA) in human beings by gas chromatography.
    Imai K; Sugiura M; Kubo H; Tamura Z; Oya K
    Chem Pharm Bull (Tokyo); 1972 Apr; 20(4):759-64. PubMed ID: 5045616
    [No Abstract]   [Full Text] [Related]  

  • 10. The metabolic pathways of L-3-O-methyldopa.
    Bartholini G; Kuruma I; Pletscher A
    J Pharmacol Exp Ther; 1972 Oct; 183(1):65-72. PubMed ID: 5080035
    [No Abstract]   [Full Text] [Related]  

  • 11. A three solvent partition chromatographic technique for the estimation of acid metabolites of catecholamines. Urinary DOMA, DOPAC and HVA.
    Vahidi A; Siva Sankar DV
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):156-60. PubMed ID: 5524313
    [No Abstract]   [Full Text] [Related]  

  • 12. Excretion of dopa metabolites.
    Kott E; Bornstein B; Eichhorn F
    N Engl J Med; 1971 Feb; 284(7):395. PubMed ID: 5539935
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolism of dihydroxyphenylalanine in human subjects.
    Smith P
    Nature; 1967 Feb; 213(5078):802-3. PubMed ID: 6031806
    [No Abstract]   [Full Text] [Related]  

  • 14. [Qualitative analysis of the main urinary metabolites of dopamine, epinephrine and norepinephrine by gas chromatography].
    Bègue RJ; Bazerolle O; Desgres J; Lallemant C; Padieu P
    Pathol Biol (Paris); 1971; 19(15):719-25. PubMed ID: 4942503
    [No Abstract]   [Full Text] [Related]  

  • 15. EEG and urinary non-catecholic amine changes during L-dopa therapy of Parkinson's disease.
    Marjerrison G; Boulton AA; Rajput AH
    Dis Nerv Syst; 1972 Mar; 33(3):164-9. PubMed ID: 5022451
    [No Abstract]   [Full Text] [Related]  

  • 16. [Catecholamine metabolism in the tissue of malignant and benign tumors of the sympathetic nervous system].
    Käser H; Türler K; Burri PH
    Schweiz Med Wochenschr; 1971 Apr; 101(13):484-7. PubMed ID: 5558918
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluorometric method for quantitatively estimating urinary dihydroxyphenylethylamine (dopamine), dihydroxyphenylalanine (dopa), and dihydroxyphenylacetic acid (dopac).
    Eichhorn F; Rutenberg A; Kott E
    Clin Chem; 1971 Apr; 17(4):296-300. PubMed ID: 5552365
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of a minor pathway of L-dopa metabolism in the intestinal lumen using a decarboxylase inhibitor (Ro 4-4602).
    Bakke OM; Scheline RR
    J Pharm Pharmacol; 1974 May; 26(5):377-9. PubMed ID: 4152920
    [No Abstract]   [Full Text] [Related]  

  • 19. Formation of p-tyramine from DOPA and DOPamine in rat brain.
    Boulton AA; Quan L
    Can J Biochem; 1970 Dec; 48(12):1287-91. PubMed ID: 5510941
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism of dihydroxyphenylalanine and tryptophan in pyridoxine-deficient rats.
    Sourkes TL; Missala K
    Ann N Y Acad Sci; 1969 Sep; 166(1):235-45. PubMed ID: 5262018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.